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Abstract
Background The risk of gallstone disease necessitating cholecystectomy after ileal resection (IR) in Crohn’s disease (CD)
patients is not well established.We studied the incidence, cumulative and relative risk of cholecystectomy after IR in CD patients,
and associated risk factors.
Methods CD patients with a first IR between 1991 and 2015 were identified in PALGA, a nationwide pathology database in the
Netherlands. Details on subsequent cholecystectomy and IRwere recorded. Yearly cholecystectomy rates from the general Dutch
population were used as a reference.
Results A cohort of 8302 (3466 (41.7%) males) CD patients after IR was identified. During the 11.9 (IQR 6.3–18.0) years
median follow-up, the post-IR incidence rate of cholecystectomy was 5.2 (95% CI 3.5–6.4)/1000 persons/year. The cumulative
incidence was 0.5% at 1 year, 2.4% at 5 years, 4.6% at 10 years, and 10.3% after 20 years. In multivariable analyses, female sex
(HR 1.9, CI 1.5–2.3), a later calendar year of first IR (HR/5-year increase, HR 1.27, CI 1.18–1.35), and ileal re-resection (time-
dependent HR 1.37, CI 1.06–1.77) were associatedwith cholecystectomy. In the last decade, cholecystectomy rates increased and
were higher in our postoperative CD population than in the general population (relative incidence ratio 3.13 (CI 2.29–4.28;
p < 0.0001) in 2015).
Conclusions Although higher in females, increasing in recent years, and higher than in the general population, the overall risk of
cholecystectomy in CD patients following IR is low and routine prophylactic measures seem unwarranted.
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Introduction
The annual incidence of newly diagnosed gallstones in
Crohn’s disease (CD) patients is twice as high as compared
to the general population.1 Ileal disease localization and pre-
vious ileal resection (IR) have both been identified as risk
factors for developing gallstones in CD patients.1,2 The under-
lying pathophysiology for the increased risk of developing
gallstones in CD patients with ileal disease or after IR is not
fully understood. A disturbance of the enterohepatic cycle of
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bilirubin, due to bile salt malabsorption in the ileum, may
increase bilirubin secretion into the bile and thereby increase
formation of gallstones. Alternative hypotheses are supersat-
uration of cholesterol in the bile due to reduced bile salt ab-
sorption or reduced motility and emptying of the
gallbladder.3–7
Data on the prevalence of gallstones diagnosed with ab-
dominal ultrasound in CD patients are variable, probably
due to the inclusion of pooled populations of both symptom-
atic and asymptomatic CD patients. The reported prevalence
ranges from respectively 10.4 to 38.5% in females and 9.4 to
25% inmales and is clearly higher as compared to the reported
prevalence in the asymptomatic general population, respec-
tively 10.5% in females and 6.5% in males.1,2,6,8–10
Available epidemiological data suggests an increased risk of
symptomatic and/or complicated gallstone disease in CD
patients.1,2,6,10 A case-control study in 429 CD patients
showed that the incidence rate of gallstones on abdominal
ultrasound was 14.35/1000 persons/year compared to 7.48/
1000 persons/year in matched hospital controls.1
Additionally, this study suggested a significant proportion of
patients with newly diagnosed gallstones would eventually
require cholecystectomy for symptomatic gallstone disease
([9/41] 22%). A major limitation of this and other reports is
the inclusion of small CD populations and lack of long-term
follow-up data. In order to interpret the clinical relevance of
the observed increased risk of gallstones in CD patients, stud-
ies assessing the risk of gallstone disease necessitating chole-
cystectomy are necessary. A high risk of cholecystectomy
after IR justifies increased alertness in symptomatic CD pa-
tients and possibly even prophylactic measures at the time of
IR, such as synchronous cholecystectomy. In this nationwide
long-term follow-up study in the Netherlands, we aimed to
assess the risk of—and identify risk factors for—
cholecystectomy during long-term follow-up after IR in CD
patients, including absolute annual and cumulative risk as well
as the relative risk as compared to the general population.
Materials and Methods
Histopathology Database
In the Netherlands, all histopathology and cytopathology re-
ports are collected in the nationwide network and registry of
histopathology and cytopathology in the Netherlands
(PALGA). Since 1991, this database has a nationwide
coverage.11 Every individual patient within the database is
identified with a unique code that allows follow-up of all
consequent pathology reports, regardless of the institute the
patient is being treated. Every record in the database contains
an excerpt combined with diagnostic codes given by the pa-
thologist who assessed the tissue. The codes used are similar
to the Systematized Nomenclature of Medicine (SNOMED)
classification of the College of American Pathologists.12 After
a report has been coded, it is submitted online to the central
database. The current study was based on data recorded in the
PALGA database between 1991 and 2015. For each patient,
the following characteristics were available: gender, date of
birth, date of pathology review, summary text, and diagnostic
code.
Patient Selection
All patients aged ≥ 18 years with an IR (ileal or ileocolonic
resection) and simultaneous histological diagnosis CD in the
period from 1991 to 2015 were identified in PALGA.
Corresponding details on subsequent IR and cholecystectomy
were identified using PALGA pathology codes (Appendix).
Patients with a diagnosis of malignancy in the initial bowel
resection specimen were excluded. Duplicate pathology re-
ports (e.g., revision material) were excluded. Furthermore,
patients with cholecystectomy prior to IR and patients of
whom the first available excerpt in our database was an ileal
re-resection were excluded. Patients with a cholecystectomy
with gallbladder carcinoma, or gallbladder specimens resected
in combination with other procedures such as hepatectomy or
Whipple procedure, were excluded form analysis. Follow-up
data were evaluated until December 2015. In addition, we
obtained the yearly cholecystectomy rates for the general
Dutch population aged ≥ 18 years from 1991 to 2015, using
PALGA pathology codes, to create a reference study popula-
tion (Appendix).
Statistical Analysis
Statistical analyses were performed with IBM SPS Statistics
version 22.0 (IBM Corp. Released 2013, IBM Corp, Armon,
NY) and R version 3.4.0 (2017-4-21, R Foundation for
Statistical Computing, Vienna, Austria) with the packages sur-
vival and splines.13,14 Data are presented as median and inter-
quartile range (IQR) for continuous variables. The PALGA
database does not contain follow-up data on date of death
unless an autopsy has been performed. Therefore, censoring
for patient death was imputed from survival data of the general
Dutch population from the Statistics Netherlands agency
(CBS).15 For each patient, the imputed follow-up was based
on life expectancy in his or her year of birth, assuming the
survival of CD patients is similar to that of the general
population.16,17 Interval between IR and cholecystectomy
and cumulative incidence of cholecystectomies was evaluated
using Kaplan-Meier survival analysis. Univariate and multi-
variate Cox-regression analysis was performed to identify fac-
tors associated with cholecystectomy.
The association of a second IR with a subsequent cholecys-
tectomy was assessed by modeling the time until a second IR
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as a time-dependent covariate. Accompanying Kaplan-Meier
estimations were made using a clock-reset approach.18 In this
figure, a cumulative incidence curve was plotted for patients
who only had one IR. Those who had a second resection
during follow-up were censored and switched to a new cumu-
lative incidence curve starting at time 0.
In addition, we assessed the yearly crude incidence rates
of cholecystectomy in our CD population as well as in the
general Dutch population. Cholecystectomy rates of the
general Dutch population were obtained from PALGA.
Data on total population numbers over calendar years were
obtained from a Dutch registry (Statistics Netherlands,
www.cbs.nl).19 Joinpoint Regression Program, version 4.
5.0.1, was used to examine significant changes in
incidence over calendar time between 1991 and 2015.20
R e l a t i v e i n c i d e n c e r a t i o s ( r e l a t i v e r i s k ) o f
cholecystectomy between our CD cohort and the general
Dutch population were calculated at yearly intervals for the
period 2001–2015 according to Altman.21
This study was conducted in accordance with the protocol
and the principles of the Declaration of Helsinki. The protocol
was approved by the Institutional Research Board of the cor-
responding center.
Results
Baseline Cohort Characteristics
A cohort of 8506 adult CD patients who underwent an ileal
resection between 1991 and 2015 was retrieved. After apply-
ing exclusion criteria, 8302 patients were included for further
analysis (Fig. 1). The majority of patients was female (4836;
58.3%) and the median (IQR) age at the first resection was
37.0 (27.0–51.0) years (Table 1).Median follow-up was 11.98
(IQR 6.31–18.05; range 0.0–25.0) years.
Cumulative Incidence of Cholecystectomy
At the end of the 25-year follow-up period, a total of 523
(6.3%) patients had undergone a cholecystectomy: 143 males
(1.7% of total population and 4.5% of male study population)
and 380 females (4.6% of total population and 7.9% of female
study population). The median (IQR) age at cholecystectomy
was 45.65 (37.36–56.62) years. The incidence rates of chole-
cystectomy at 1, 5, 10, and 20 years of follow-up were 0.5%,
2.4%, 4.6%, and 10.3%, respectively (Fig. 2). Female CD
patients had higher incidence rates of cholecystectomy than
male patients: 0.6% vs. 0.3%, 2.8% vs. 1.9%, 5.7% vs. 3.1%,
and 12.7% vs. 6.7%, at 1, 5, 10, and 20 years, respectively
(Fig. 2).
Factors Associated with Cholecystectomy
In univariable analysis, female patients had a significantly
higher probability of cholecystectomy than male patients
(HR 1.84 (95% confidence interval [CI] 1.52–2.23);
p < 0.001; Fig. 2). Furthermore, a later calendar year of the
first IR was associated with an increased probability of chole-
cystectomy (HR/5-year increase 1.25; CI 1.16–1.34; Fig. 3).
Finally, ileal re-resection during follow-up was associated
with a slightly increased probability of cholecystectomy
(time-dependent HR 1.30; CI 1.01–1.68; p = 0.045; Fig. 4).
All these variables remained significantly associated with a
cholecystectomy in multivariable analysis (Table 2).
Yearly Cholecystectomy Rates in CD Patients
and the General Population
During the median follow-up of 12 years, the incidence rate of
cholecystectomy in our CD cohort was 5.2 (95% CI 3.5–6.4)/
1000 persons/year. Females had a significantly higher rate
than males (6.4 [95% CI 4.7–5.6] vs. 3.5 [95% CI 2.9–4.1]/
1000 persons/year; p < 0.0001). Absolute cholecystectomy
rates per calendar year were higher in our postoperative CD
population (Fig. 5a) than in the general Dutch population
(Fig. 5b) between 1991 and 2015. Over the last decade, the
relative incidence ratio for our postoperative CD cohort, com-
pared to the general population, varied between 1.28 (95% CI
1.28–2.81; p = 0.001) in 2002 and 3.13 (95% CI 2.29–4.28;
p < 0.0001) in 2015. For males, these ratios were 2.16 (95%
CI 1.028–4.52; p = 0.042) and 3.25 (95% CI 1.85–5.72;
p < 0.0001) and for females 1.68 (95% CI 1.06–2.67; p =
0.027) and 2.90 (1.99–4.22; p < 0.0001), respectively
(Supplementary table 1). In accordance with the observed in-
crease in the probability of cholecystectomy after IR in our
CD population over calendar time, there was an increase in the
crude incidence rates of cholecystectomies within the study
population (Fig. 5a), which was also observed in the general
Dutch population with a significant increase over calendar
time from 48/100,000 in 1991 to 185/100,000 in 2006, and
remained relatively stable with a minimal decline after 2012
(Fig. 5b).
Discussion
It has been well established that CD patients are at an in-
creased risk of gallstone development, especially those with
ileal involvement. The clinical relevance of this observed in-
crease has however remained unclear. This large nationwide
long-term follow-up study is the first to assess the risk of
gallstone disease necessitating an intervention following IR,
namely cholecystectomy. Our results show that, although over
the past years the incidence of cholecystectomy in post-IR CD
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patients has increased and is currently higher than that in the
general population, the annual incidence of cholecystectomy
after IR is low. With thorough analyses, we were able to iden-
tify patients more likely to require cholecystectomy following
Fig. 1 Flowchart of inclusion.
CD, Crohn’s disease; IR, ileal
resection
Table 1 Cohort characteristics
Study population (N = 8302)
Sex, male 3466 (41.7%)
Age at first IR 37.0 (22.0–51.0)
Calendar year of first resection
1991–1995 1751 (21.1%)
1996–2000 1848 (22.3%)
2001–2005 1689 (20.3%)
2006–2010 1543 (18.6%)
2011–2015 1471 (17.7%)
Number of IR
1 resection 7240 (87.2%)
2 resections 854 (10.3%)
> 2 resections 208 (2.5%)
Data are presented as frequency (%) or median (IQR)
IR, ileal resection
Fig. 2 Cholecystectomy risk after ileal resection. Kaplan-Meier estimates
of the occurrence of cholecystectomy in the total cohort stratified
according to gender. Females had a significantly higher probability of
cholecystectomy than males (log-rank test < 0.001 and HR 1.84 [95%
CI 1.52–2.23; p < 0.001])
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IR. Female patients, those undergoing ileal re-resection, and
patients with a later calendar year of first IR have an increased
probability of cholecystectomy.
The observed incidence rate of cholecystectomy in our CD
population after IR of 5.2/1000 persons/year is evidently low-
er than the reported incidence rate of gallstones found by
ultrasound examination in CD patients in general. A large
case-control study in 429 CD patients reported an incidence
rate of gallstones on abdominal ultrasound of 14.35/1000 per-
sons/year, which was significantly higher than that in matched
controls (7.75/1000 persons/year, p = 0.012).1 Additionally, it
was shown that in a subgroup of CD patients with newly
developed gallstones, about 22% of the patients (9/41)
eventually required cholecystectomy for symptomatic stones.
Our nationwide study substantially adds to these data by de-
scribing the clinical consequences of gallstones in a large
long-term follow-up cohort of CD patients. Our study shows
that in a potentially high-risk population for gallstone disease,
only a minority of patients of approximately 10.5% during
20 years will eventually require a cholecystectomy.
The observed cumulative incidence of cholecystectomy of
4.6% within 15 years of follow-up in our study is evidently
higher than that observed in the general population. A recent
large population-based cohort study of over 65,000 individ-
uals found a cumulative incidence of cholecystectomy for
gallstone disease of 1.8% within 15 years of follow-up.22 To
date, the only published study on gallstone disease necessitat-
ing cholecystectomy in CD patients was a case-control study
including 134 CD patients with ileitis.10 This study demon-
strated that the incidence of cholecystectomy was not signifi-
cantly different from an age- and sex-matched control group.
The nationwide data in the current study significantly adds to
previous reports by quantifying the rate of cholecystectomy in
absolute and relative risk, annual cholecystectomy risk, and
cumulative cholecystectomy risk during long-term follow-up.
Female sex is an important risk factor for cholecystectomy
after IR in our study. This finding is in agreement with data
from the general population, in which female sex has been
identified as an important risk factor for gallstone
development.9,23 Especially women in fertile years are more
likely to form gallstones as compared to men. This difference
narrows after menopause.24,25 However, previous data on the
prevalence of gallstones in CD patients indicate there are no
gender differences. A study in 251 CD patients showed no
gender differences in the prevalence of gallstones (27% in
females vs. 29% in males).2 In accord, a more recent study
in 330 CD patients reported similar results with a prevalence
of 25% in females vs. 25% in males as found by ultrasound
examination.6 A possible explanation for the observed differ-
ence in our cohort may be the long-term follow-up and the
larger number of included CD patients. Alternatively, the dif-
ference may be explained by our cohort’s relatively young
median age of 37 years.
In line with expectations, ileal re-resection was associated
with cholecystectomy. Previous studies have shown that the
prevalence of gallstones is associated with the number of bow-
el resections and is significantly increased in patients in whom
more than 10 cm of the ileum was resected.2,26 In the current
study, we assessed re-resection as a surrogate for the length of
intestine removed by surgery and/or CD severity, and this was
associated with an increased risk of cholecystectomy.
To our knowledge, this is the first study to report on an
increase in gallstone disease necessitating cholecystectomy
after IR in CD patients over calendar time. Our findings may
well reflect the global trend of increasing gallstone prevalence
observed in necroptic27 and ultrasound studies.24,28 In
Fig. 4 Cumulative incidence of cholecystectomy in a clock-reset ap-
proach: patients who only underwent one IR during their follow-up are
in the solid line. Patients who underwent a second IR are represented in
the solid line until they have a second IR. They are then censored and
switched to a new survival curve (dotted line), which is then reset as time
0 for further follow-up. Patients with an ileal re-resection during follow-
up had an increased probability of a cholecystectomy during their further
follow-up. IR, ileal resection
Fig. 3 Hazard ratio of cholecystectomy over calendar year of first ileal
resection. Hazard ratio (solid line) and corresponding 95% confidence
interval (dashed lines) for the association between calendar year of first
IR and cholecystectomy. A later calendar year of the first IR was
associated with an increasing hazard for cholecystectomy
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addition, cholecystectomy rates have increased, especially in
the first decade after 1990.29–31 This increase may be attribut-
ed to the introduction of laparoscopic cholecystectomy in
1990, which may have lowered the threshold for a surgical
procedure in cases of uncomplicated gallstones.32,33 Still, the
cholecystectomy rates may vary greatly between different
countries. A recent nationwide study from Sweden, which
assessed a total of 130,800 laparoscopic and 47,641 open
cholecystectomies performed between 1998 and 2013,
showed the annual rates of cholecystectomies remained
stable.34 In contrast, our data covering all cholecystectomies
performed within the Netherlands between 1991 and 2015
indicates annual rates have increased between 1991 and
2007 and remained relatively stable with a minimal decline
after 2012. This corresponds with the observed increase in
probability of cholecystectomy after IR in our study
population.
One of the strengths of our study is the selection of a large
nationwide cohort with long-term follow-up data, with strin-
gent inclusion criteria of a histology-proven CD and the use of
the general Dutch population as a reference population. These
data allowed a thorough assessment of gallstone disease ne-
cessitating cholecystectomy including risk factors, absolute,
relative, and cumulative risk. In addition, due to the nation-
wide coverage of PALGA, there was a long-term follow-up
for each individual patient after IR and full-scale cholecystec-
tomy detection. However, some limitations need to be consid-
ered. Firstly, our inclusion criteria for a biopsy-proven CD
(SNOMED D62160) might have been too stringent as some
pathology reports only include SNOMED codes for ulcer,
granuloma, or inflammation. Secondly, the PALGA database
provides limited data on patient characteristics, making further
subgroup analysis impossible. No data on initial diagnosis of
CD and thus duration and/or severity of disease, length of the
resected segment, ileal involvement earlier in the disease
course, or other known risk factors (e.g., BMI, bariatric sur-
gery) are provided. It would be highly interesting to assess
these factors in such a large cohort. In addition, the PALGA
database does not contain a date of CD diagnosis, thereby
limiting the possibilities for time-to-event and risk factor anal-
ysis in a cohort of CD patients without IR. Further studies
could focus on the comparison of the risk of cholecystectomy
in CD patients without IR and those with IR. This would
provide further evidence for the hypothesized role of IR in
the development of gallstones in CD patients. Finally, data
on the indication of cholecystectomy are lacking.
Cholecystectomy rates in CD patients might be higher due
Table 2 Covariates associated with cholecystectomy
Univariable analyses Multivariable analyses
HR 95% CI p HR 95% CI p
Female sex 1.839 1.517–2.229 < 0.001 1.856 1.532–2.250 < 0.001
Age at first resection 1.000 0.994–1.005 0.920
Year of first IR, per 5 years 1.252 1.164–1.341 < 0.001 1.265 1.177–1.350 < 0.001
Ileal re-resection during FUa 1.299 1.006–1.678 0.045 1.369 1.059–1.769 0.016
a These hazard ratios were obtained by considering re-resection as a time-dependent covariate in univariable and multivariable analyses
HR, hazard ratio; CI, confidence interval; IR, ileal resection; FU, follow-up
Fig. 5 a Incidence rates of cholecystectomy per calendar year in CD
patients. Crude incidence rates of cholecystectomy increased in our
postoperative CD population from 2001 to 2015. Cholecystectomy rates
between 1991 and 2001 are not presented in this figure because these
initial years may not be representative as CD patients who underwent IR
before 1991 are not included as background population. b Incidence rates
of cholecystectomy in the general Dutch population per calendar year.
Crude incidence rates of cholecystectomy increase over calendar year in
the general Dutch population in males and females. The asterisk indicates
joint points where the annual percentage change (APC) is significantly
different from 0 at the alpha = 0.05 level, indicating a significant trend
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to frequent contact with health care professionals and conse-
quently a lower threshold for performing an abdominal ultra-
sound and a higher diagnosis rate of incidental gallstones.
Furthermore, cholecystectomy may have been performed for
indications other than complications of chole(cysto)lithiasis,
e.g., polyp, tumor-like lesions, acalculous cholecystitis, and
unexplained abdominal pain. However, in general, only a
small proportion of patients undergo cholecystectomy for
these indications.34
In conclusion, this large nationwide study shows that annual
incidence of cholecystectomy in CD patients after IR is 0.5%
and increases almost linearly during follow-up to 10.5% after
20 years. Female sex, re-resection, and a later year of IR are
associated with cholecystectomy. The incidence of cholecystec-
tomy after IR in CD patients is currently three times higher than
that in the general population. Nonetheless, overall, the risk of
cholecystectomy is low. While this risk may justify increased
alertness of gallstone disease and a lower threshold for abdom-
inal ultrasound in symptomatic CD patients following ileal re-
section, it does not seem to warrant prophylactic synchronous
cholecystectomy during IR in all CD patients.
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Appendix
PALGA diagnosis codes used in the analysis of our CD
cohort
Crohn’s disease: D62160
Ileum or ileocecal: T65200, T65500T67000, T65500,
M81406
Resection: P11100, P11200, P11101
Gallbladder: T57000
Adenocarcinoma M81403
Metastasis, adenocarcinoma M81406
Metastasis, carcinoma M80106
Intramucosal carcinoma M80105
PALGA codes used to extract cholecystectomy rates
in general Dutch population
Cholecystectomy: T57000111000
Gallbladder and excision: T57___ AND *54*
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
1. Parente F, Pastore L, Bargiggia S, Cucino C, Greco S, Molteni M,
Ardizzone S, et al. Incidence and risk factors for gallstones in pa-
tients with inflammatory bowel disease: A large case-control study.
Hepatology 2007;45:1267–1274.
2. Fraquelli M, Losco A, Visentin S, Cesana BM, Pometta R, Colli A,
Conte D. Gallstone disease and related risk factors in patients with
Crohn disease: analysis of 330 consecutive cases. Arch Intern Med
2001;161:2201–2204.
3. Lapidus A, Akerlund JE, Einarsson C. Gallbladder bile composi-
tion in patients with Crohn’s disease. World J Gastroenterol
2006;12:70–74.
4. Brink MA, Slors JFM, Keulemans YCA, Mok KS, De Waart DR,
Carey MC, Groen AK, et al. Enterohepatic cycling of bilirubin: A
putative mechanism for pigment gallstone formation in ileal
Crohn’s disease. Gastroenterology 1999;116:1420–1427.
5. Pereira SP, Bain IM, Kumar D, Dowling RH. Bile composition in
inflammatory bowel disease: ileal disease and colectomy, but not
colitis, induce lithogenic bile. Aliment Pharmacol Ther 2003;17:
923–933.
6. Hutchinson R, Tyrrell PN, Kumar D, Dunn JA, Li JK, Allan RN.
Pathogenesis of gall stones in Crohn’s disease: an alternative expla-
nation. Gut 1994;35:94–97.
7. Vu MK, Gielkens HA, van Hogezand RA, van Oostayen JA,
Lamers CB, Masclee AA. Gallbladder motility in Crohn disease:
influence of disease localization and bowel resection. Scand J
Gastroenterol 2000;35:1157–1162.
8. Lapidus A, Bangstad M, Astrom M, Muhrbeck O. The prevalence
of gallstone disease in a defined cohort of patients with Crohn’s
disease. Am J Gastroenterol 1999;94:1261–1266.
9. Attili AF, Carulli N, Roda E, Barbara B, Capocaccia L, Menotti A,
Okoliksanyi L, et al. Epidemiology of gallstone disease in Italy:
prevalence data of the Multicenter Italian Study on Cholelithiasis
(M.I.COL.). Am J Epidemiol 1995;141:158–165.
10. Chew SS, Ngo TQ, Douglas PR, Newstead GL, SelbyW, Solomon
MJ. Cholecystectomy in patients with Crohn’s ileitis. Dis Colon
Rectum 2003;46:1484–1488.
11. Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A,
van Krieken JH, Meijer GA. Pathology databanking and
biobanking in The Netherlands, a central role for PALGA, the
J Gastrointest Surg
nationwide histopathology and cytopathology data network and
archive. Cell Oncol 2007;29:19–24.
12. Cote RA, Robboy S. Progress in medical information management.
Systematized nomenclature of medicine (SNOMED). Jama
1980;243:756–762.
13. Team. RC. R Foundation for Statistical Computing, Vienna,
Austria, 2017a. URL https://www.R-project.org/. R: A Language
and Environment for Statistical Computing.
14. Therneau. TM. A Package for Survival Analysis in S. URL https://
CRAN.R-project.org/package=survival. version 2.38. 2015.
15. Gezonde levensverwachting; vanaf 1981 In: Centraal Bureau voor
de Statistiek (CBS); 2015.
16. Hovde O, Kempski-Monstad I, Smastuen MC, Solberg IC,
Henriksen M, Jahnsen J, Stray N, et al. Mortality and causes of
death in Crohn’s disease: results from 20 years of follow-up in the
IBSEN study. Gut 2014;63:771–775.
17. van den Heuvel TRA, Jeuring SFG, Zeegers MP, van Dongen
DHE, Wolters A, Masclee AAM, Hameeteman WH, et al. A 20
year temporal change analysis in incidence, presenting phenotype
and mortality in the Dutch IBDSL cohort - Can diagnostic factors
explain the increase in IBD incidence? J Crohns Colitis 2017.
18. Putter H, FioccoM, Geskus RB. Tutorial in biostatistics: competing
risks and multi-state models. Stat Med 2007;26:2389–2430.
19. Bevolking kerncijfers, gezonde levensverwachting, vanaf 1991. In:
Statline; Centraal Bureau voor de Statistiek; 2017.
20. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for
joinpoint regression with applications to cancer rates. Stat Med
2000;19:335–351.
21. Altman DG. Practical Statistics for Medical Research. London:
Chapman and Hall. , 1991.
22. Talseth A, Ness-Jensen E, Edna TH, Hveem K. Risk factors for
requiring cholecystectomy for gallstone disease in a prospective
population-based cohort study. Br J Surg 2016.
23. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic
differences in gallbladder disease in the United States.
Gastroenterology 1999;117:632–639.
24. Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cho-
lelithiasis and cancer. Gut Liver 2012;6:172–187.
25. Shaffer EA. Gallstone disease: Epidemiology of gallbladder stone
disease. Best Pract Res Clin Gastroenterol 2006;20:981–996.
26. Hill GL,MairWS,Goligher JC. Gallstones after ileostomy and ileal
resection. Gut 1975;16:932–936.
27. Acalovschi M, Dumitrascu D, Caluser I, Ban A. Comparative prev-
alence of gallstone disease at 100-year interval in a large Romanian
town, a necropsy study. Dig Dis Sci 1987;32:354–357.
28. Aerts R, Penninckx F. The burden of gallstone disease in Europe.
Aliment Pharmacol Ther 2003;18 Suppl 3:49–53.
29. Lam CM, Murray FE, Cuschieri A. Increased cholecystectomy rate
after the introduction of laparoscopic cholecystectomy in Scotland.
Gut 1996;38:282–284.
30. McMahon AJ, Fischbacher CM, Frame SH, MacLeod MC. Impact
of laparoscopic cholecystectomy: a population-based study. Lancet
2000;356:1632–1637.
31. Attili AF, De Santis A, Capri R, Repice AM,Maselli S. The natural
history of gallstones: the GREPCO experience. The GREPCO
Group. Hepatology 1995;21:655–660.
32. Steinle EW, VanderMolen RL, Silbergleit A, CohenMM. Impact of
laparoscopic cholecystectomy on indications for surgical treatment
of gallstones. Surg Endosc 1997;11:933–935.
33. Mallon P, White J, McMenamin M, Das N, Hughes D, Gilliland R.
Increased cholecystectomy rate in the laparoscopic era: a study of
the potential causative factors. Surg Endosc 2006;20:883–886.
34. Noel R, Arnelo U, Enochsson L, Lundell L, Nilsson M, Sandblom
G. Regional variations in cholecystectomy rates in Sweden: impact
on complications of gallstone disease. Scand J Gastroenterol
2016;51:465–471.
J Gastrointest Surg
